WHO: Indian strain of COVID-19 resistant to antibodies
Mutations of the Indian strain of COVID-19 indicate its high infectivity and resistance to antibodies in both those who have been ill and vaccinated, the World Health Organization reported.
New varieties of the virus have been discovered in India, including B.1.617. It is a variant with mutations E484Q and L452R that was first identified in India from samples collected on December 1, 2020.
According to preliminary research results, the L452R mutation may interfere with the effectiveness of certain monoclonal antibody treatments. E484Q can neutralize antibodies. Thus, the antibodies that have appeared in a person who has recovered from COVID-19 will not help in the fight against Indian mutations.
Moreover, the new strain is also thought to be highly virulent, which means it is more likely to infect and cause disease.
WHO experts have not yet figured out what influenced the virus mutations in India. One of the factors could be the holding of mass events that increased its spread, as well as the mitigation of antiquated measures in the country.




















Armenian Company E-auto to Officially Represent HONGQI Vehicles in Georgia
2% Cashback on Payments Made with AraratBank Arca Cards
Unibank’s perpetual bonds have been listed on the Armenia Securities Exchange
“My phone rang…”: IDBank warns about a rise in fraud using the “call from the bank” scheme.
Ucom Spring Offer: HONOR X7d 5G Smartphone and Valuable Gifts
Trust and reach across the globe
Ucom Is Recognized as Armenia’s No. 1 Operator for the Fastest Mobile Internet and the Best Fixed Ne...
AraratBank: Update+ - New Loan Offer with 2% Cashback
Choosing the Best Gifts for March 8 and Paying with the Idram&IDBank App
Individuals and businesses, near and far, all welcome